Crossmark

Chidamide, Decitabine, Cytarabine, Aclarubicin, and Granulocyte Colony-stimulating Factor Therapy for Patients with Relapsed/Refractory Acute Myeloid Leukemia: A Retrospective Study from a Single-Center

Crossref DOI link: https://doi.org/10.1007/s11596-023-2805-7

Published Online: 2023-12-07

Published Print: 2023-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kong, Fan-cong

Qi, Ling

Zhou, Yu-lan

Yu, Min

Huang, Wen-feng

Li, Fei
License Information

Text and Data Mining valid from 2023-12-01

Version of Record valid from 2023-12-01
More Information

Article History

Received: 26 November 2022

Accepted: 19 September 2023

First Online: 7 December 2023

Conflict of Interest Statement

: On behalf of all authors, the corresponding author states that there is no conflict of interest to disclose.

Document is current

Any future updates will be listed below